Search

Background. Although norovirus is the most common cause of gastroenteritis, there are few data on the community incidence of infection/disease or the patterns of acquired immunity or innate resistance to norovirus. Methods. We followed a community-based birth cohort of 194 children in Ecuador with the aim to estimate (1) the incidence of norovirus gastroenteritis from birth to age 3 years, (2) the protective effect of norovirus infection against subsequent infection/disease, and (3) the association of infection and disease with FUT2 secretor status. Results. Over the 3-year period, we detected a mean of 2.26 diarrheal episodes per child (range, 0-12 episodes). Norovirus was detected in 260 samples (18%) but was not found more frequently in diarrheal samples (79 of 438 [18%]), compared with diarrhea-free samples (181 of 1016 [18%]; P = .919). A total of 66% of children had at least 1 norovirus infection during the first 3 years of life, and 40% of children had 2 infections. Previous norovirus infections were not associated with the risk of subsequent infection. All genogroup II, genotype 4 (GII.4) infections were among secretor-positive children (P < .001), but higher rates of non-GII.4 infections were found in secretor-negative children (relative risk, 0.56; P = .029). Conclusions. GII.4 infections were uniquely detected in secretor-positive children, while non-GII.4 infections were more often found in secretor-negative children. [ABSTRACT FROM AUTHOR]

Investigates the cytokine and antibody response to adult and larval stages of Ascaris lumbricoides in infected young adults living in an endemic area of Ecuador. Frequencies of peripheral blood mononuclear cells secreting interleukin (IL)-10, interferon-gamma, IL-4 and IL-5 in infected young adults; Levels of A. lumbricoides-specific antibodies in plasma from infected individuals.

Studies the vibriocidal antibody response to the oral cholera vaccine in children infected with Ascaris lumbricoides as well as the effect of albendazole pretreatment on the postvaccination response. Greater postvaccination rates of seroconversion in the treatment group that received albendazole; Greater rates of seroconversion and mean titer observed in the albendazole groupin subjects with non-O ABO blood groups.

Assesses the safety and biologic effects of recombinant human interleukin-10 in acute systemic inflammation using the antibiotic-induced Jarisch-Herxheimer reaction of Louse-borne relapsing fever. Pathogenesis of the systemic inflammatory response syndrome; Consequences associated with uncontrolled production of potent mediators; Onset of spirochete destruction.

Analyzes the role of eosinophil activation and sequestration in the development and severity of adverse reactions after treatment of Onchocerca volvulus infection with ivermectin. Decline in eosinophil counts in ivermectin-treated groups; Increase in the circulating levels of interleukin-5 and eosinophil-derived neurotoxin; Slin microfilarial densities before and after treatment.